Talaris Therapeutics, Inc. (NASDAQ:TALS) Sees Large Decline in Short Interest

Talaris Therapeutics, Inc. (NASDAQ:TALS – Get Free Report) was the target of a significant decrease in short interest in the month of June. As of June 30th, there was short interest totalling 270,300 shares, a decrease of 71.7% from the June 15th total of 955,200 shares. Based on an average daily volume of 629,200 shares, […]

Related Keywords

United States ,Suzanne Ildstad ,Talaris Therapeutics Company Profile ,Virtu Financial ,Talaris Therapeutics Inc ,Nasdaq ,Commonwealth Equity Services ,Deutsche Bank ,Bailard Inc ,Susquehanna International Group ,Securities Exchange Commission ,Talaris Therapeutics ,Get Free Report ,Therapeutics Trading Down ,Director Suzanne Ildstad ,Exchange Commission ,Equity Services ,International Group ,Talaris Therapeutics Daily ,Nasdaq Tals ,Metals ,Medical ,Stocks ,Options ,Put ,Call ,